Zehra Arkir

Statistics

Publications

Citations

238

H-Index

Active since

2013

Affiliations

Guy's and St Thomas' NHS Foundation Trust(Current)

King's College London

St Thomas' Hospital

Royal Devon & Exeter NHS Foundation Trust

Zehra Arkir is an author at Guy's and St Thomas' NHS Foundation Trust specializing in pharmacotherapy, inflammatory disease pharmacotherapy, and clinical pharmacology.

ORCID

Publications per year

2013–2021

Publications

Predicting treatment response in psoriasis using serum levels of adalimumab and etanercept: a single-centre, cohort study

Satveer K. Mahil, Zehra Arkir, G.K. Richards et al. · British Journal of Dermatology · 2013 · 67 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

Infliximab and adalimumab drug levels in Crohn's disease: contrasting associations with disease activity and influencing factors

Mark G. Ward, Ben Warner, N Unsworth et al. · Alimentary Pharmacology & Therapeutics · 2017 · 62 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Adalimumab and Infliximab Impair SARS-CoV-2 Antibody Responses: Results from a Therapeutic Drug Monitoring Study in 11 422 Biologic-Treated Patients

Neil Chanchlani, Simeng Lin, Desmond Chee et al. · Journal of Crohn s and Colitis · 2021 · 47 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +17

Therapeutic thresholds for golimumab serum concentrations during induction and maintenance therapy in ulcerative colitis: results from the GO‐LEVEL study

Mark Samaan, Georgina Cunningham, Aravind Gokul Tamilarasan et al. · Alimentary Pharmacology & Therapeutics · 2020 · 23 citations

Pharmacy, Immunology, Pharmacotherapy +17

Wide variation in the use and understanding of therapeutic drug monitoring for anti-TNF agents in inflammatory bowel disease: an inexact science?

Mark Samaan, Zehra Arkir, Tariq Ahmad et al. · Expert Opinion on Biological Therapy · 2018 · 22 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +15

1–5 of 6